Showing 2281-2300 of 8875 for: Cochrane Systematic Reviews Back
- Dressings and topical agents for treating venous leg ulcers
Cochrane Systematic Reviews, 15-Jun-2018
Venous leg ulcers are open skin wounds on the lower leg which can be slow to heal, and are both painful and costly. The point prevalence of open venous leg ulcers in the UK is about 3 cases per 10,000 people, and many people experience recurrent episodes
- Dressings for healing venous leg ulcers
Cochrane Systematic Reviews, 6-May-2014
Venous leg ulcers, sometimes called varicose or stasis ulcers, are a consequence of damage to the valves in the veins of the legs, leading to raised venous pressure. Venous ulcers are characterised by a cyclical pattern of healing and recurrence. The main
- Dressings for superficial and partial thickness burns
Cochrane Systematic Reviews, 28-Mar-2013
An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are c
- Dressings for the prevention of surgical site infection
Cochrane Systematic Reviews, 20-Dec-2016
Surgical wounds (incisions) heal by primary intention when the wound edges are brought together and secured, often with sutures, staples, or clips. Wound dressings applied after wound closure may provide physical support, protection and absorb exudate. Th
- Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews
Cochrane Systematic Reviews, 14-Jul-2015
Foot ulcers in people with diabetes mellitus are a common and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from. A clear and current overview of current evide
- Driving assessment for maintaining mobility and safety in drivers with dementia
Cochrane Systematic Reviews, 29-Aug-2013
Demographic changes are leading to an increase in the number of older drivers: as dementia is an age-related disease, there is also an increase in the numbers of drivers with dementia. Dementia can impact on both the mobility and safety of drivers, and th
- Droperidol for psychosis‐induced aggression or agitation
Cochrane Systematic Reviews, 15-Dec-2016
People experiencing acute psychotic illnesses, especially those associated with agitated or violent behaviour, may require urgent pharmacological tranquillisation or sedation. Droperidol, a butyrophenone antipsychotic, has been used for this purpose in se
- Droperidol for treatment of nausea and vomiting in palliative care patients
Cochrane Systematic Reviews, 27-Nov-2014
This is an updated version of the original Cochrane review published in Issue 10, 2010, on droperidol for the treatment of nausea and vomiting in palliative care patients. Nausea and vomiting are common symptoms in patients with terminal illness and can b
- Drug interventions for the treatment of obesity in children and adolescents
Cochrane Systematic Reviews, 29-Nov-2016
Child and adolescent obesity has increased globally, and can be associated with significant short- and long-term health consequences.
- Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children
Cochrane Systematic Reviews, 19-Dec-2017
Tonic-clonic convulsions and convulsive status epilepticus (currently defined as a tonic-clonic convulsion lasting at least 30 minutes) are medical emergencies and require urgent and appropriate anticonvulsant treatment. International consensus is that an
- Drug therapies for reducing gastric acidity in people with cystic fibrosis
Cochrane Systematic Reviews, 27-Apr-2021
Malabsorption of fat and protein contributes to poor nutritional status in people with cystic fibrosis. Impaired pancreatic function may also result in increased gastric acidity, leading in turn to heartburn, peptic ulcers and the impairment of oral pancr
- Drug therapy for chronic idiopathic axonal polyneuropathy
Cochrane Systematic Reviews, 20-Jun-2017
Chronic idiopathic axonal polyneuropathy (CIAP) is an insidiously progressive sensory or sensorimotor polyneuropathy that affects elderly people. Although severe disability or handicap does not occur, CIAP reduces quality of life. CIAP is diagnosed in 10%
- Drug therapy for delirium in terminally ill adults
Cochrane Systematic Reviews, 21-Jan-2020
Delirium is a syndrome characterised by an acute disturbance of attention and awareness which develops over a short time period and fluctuates in severity over the course of the day. It is commonly experienced during inpatient admission in the terminal ph
- Drug therapy for obstructive sleep apnoea in adults
Cochrane Systematic Reviews, 30-Apr-2013
The treatment of choice for moderate to severe obstructive sleep apnoea (OSA) is continuous positive airways pressure (CPAP) applied via a mask during sleep. However, this is not tolerated by all individuals and its role in mild OSA is not proven. Drug th
- Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
Cochrane Systematic Reviews, 5-Jun-2013
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is the most common neurodegenerative disorder of the motor system in adults. Pain in ALS is a frequent symptom especially in the later stages of disease and can have a pronounc
- Drug therapy for preventing post‐dural puncture headache
Cochrane Systematic Reviews, 28-Feb-2013
Post-dural (post-lumbar or post-spinal) puncture headache (PDPH) is one of the most common complications of diagnostic, therapeutic or inadvertent lumbar punctures. Many drug options have been used to prevent headache in clinical practice and have also be
- Drug therapy for symptoms associated with anxiety in adult palliative care patients
Cochrane Systematic Reviews, 18-May-2017
This is an update of a Cochrane Review first published in 2004 (Issue 1) and previously updated in 2012 (Issue 10). Anxiety is common in palliative care patients. It can be a natural response to the complex uncertainty of having a life-limiting illness or
- Drug therapy for the management of cancer-related fatigue
Cochrane Systematic Reviews, 1-Aug-2010
This review is an update of a previously published review in The Cochrane Database of Systematic Reviews (Issue 1 2008). Cancer-related fatigue (CRF) is common, under-recognised and difficult to treat. There have been studies looking at drug interventions
- Drug therapy for treating post‐dural puncture headache
Cochrane Systematic Reviews, 15-Jul-2015
This is an updated version of the original Cochrane review published in Issue 8, 2011, on 'Drug therapy for treating post-dural puncture headache'.
- Drug treatment for facioscapulohumeral muscular dystrophy
Cochrane Systematic Reviews, 19-Apr-2004
Facioscapulohumeral muscular dystrophy is a progressive muscle disease which has no agreed treatment. Early suggestions that corticosteroids might be helpful were not supported by a subsequent open label study. The beta 2 adrenergic agonist albuterol, als
